BusinessSPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief TherapyBy Nasdaq OMXMay 15, 2017, 1:04 PM UTC
BusinessSPR Therapeutics Names Dave Youngberg Vice President of SalesBy Nasdaq OMXJan 17, 2017, 2:30 PM UTC
